共 54 条
[11]
Vadhan-Raj S., Keating M., LeMaistre A., Et al., Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes, N. Engl. J. Med., 317, pp. 1545-1552, (1983)
[12]
Vadhan-Raj S., Kedting M., LeMaistre A., Et al., Stimulation of hematopoiesis in patients with bone marrow failure and in patients with malignancy by recombinant human granulocyte-macrophage colony-stimulating factor, Blood, 72, pp. 134-141, (1988)
[13]
Vadhan-Raj S., Hittelman W.N., Ventura C., Et al., Granulocyte-macrophage colony-stimulating factor and myelodysplastic syndromes, N. Engl. J. Med., 319, pp. 51-53, (1988)
[14]
Antin J.H., Smith B.R., Holmes W., Et al., Phase I/II study of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes and aplastic anemia, Blood, 72, pp. 705-713, (1988)
[15]
Ganser A., Valkers B., Greher J., Et al., Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: a phase I/II trial, Blood, 73, pp. 31-37, (1989)
[16]
Thompson J.A., Lee D.J., Kidd P., Et al., Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, phar-macokinetics, and hematological effects, J. Clin. Oncol., 7, pp. 629-637, (1989)
[17]
Henmann F., Lindemann A., Klein H., Et al., Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts, Leukemia, 3, pp. 335-339, (1989)
[18]
Gradishar W.J., LeBeau M.M., O'Laughlin R., Vardi-Man J.W., Larson R.A., Clinical and cytogenetic responses to granulocyte-macrophage colony-stimulating factor in therapy-related myelodysplasia, Blood, 80, (1992)
[19]
Rosenfeld C.S., Sulecki M., Evans C., Et al., Comparison of intravenous versus subcutaneous recombinant granulocyte-macrophage colony-stimulating factor in patients with primary myelodysplasia, Exp. Hematol., 19, pp. 273-277, (1991)
[20]
Estey E.H., Kurzrock R., Talpaz M., Et al., Effects of low dose of recombinant human granulocyte-macrophage colony-stimulating factor (EM-CSF) in patients with myelodysplastic syndromes, Br. J. Haematol., 77, pp. 291-295, (1991)